Abivax S.A.
obefazimod
ulcerative colitis
Resolved
8days ago
Phase 2 readout · Jun 29, 2026
What's at stake
Phase 2 trial results for obefazimod in ulcerative colitis are due Jun 29, 2026. A clean hit validates the program; a miss can gap the stock down hard.
Primary source
· SEC 6-K
verified 13h ago
“The ENHANCE-CD Phase 2b induction trial is ongoing with top-line results currently expected to be reported in mid-year 2027.”